TNBC is an aggressive breast cancer subtype lacking estrogen, progesterone, and human epidermal growth factor receptor 2 (HER2) receptors, often exhibiting poor prognosis and limited therapeutic options [47]. The gene discussed is ERBB2; the disease is breast carcinoma.